UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044135
Receipt number R000050381
Scientific Title A Study on the Effect of Food Containing Plant Extract on Absorption of Protein -A Randomized, Double-blind, Placebo-controlled, Cross-over Study-
Date of disclosure of the study information 2021/05/07
Last modified on 2021/05/06 18:14:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effect of Food Containing Plant Extract on Absorption of Protein
-A Randomized, Double-blind, Placebo-controlled, Cross-over Study-

Acronym

A Study on the Effect of Food Containing Plant Extract on Absorption of Protein

Scientific Title

A Study on the Effect of Food Containing Plant Extract on Absorption of Protein
-A Randomized, Double-blind, Placebo-controlled, Cross-over Study-

Scientific Title:Acronym

A Study on the Effect of Food Containing Plant Extract on Absorption of Protein

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of food containing plant extract on absorption of protein

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

blood amino acid concentration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Food containing plant extract, 1 weeks consumption. Wash out. Food not containing plant extract, 1 weeks consumption.

Interventions/Control_2

Food not containing plant extract, 1 weeks consumption. Wash out. Food containing plant extract, 1 weeks consumption.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1) Healthy males and females aged 20 to 59 years-old.
2)Subjects with low protein intake.
3)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

Subjects (who)
1)have a chronic disease and regularly use medications.
2)can't stop using supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) during test periods.
3)can't stop drinking from 2 days before each measurement.
4)have declared allergic reaction to ingredients contained in test foods or loading foods.
5)contract or are under treatment for diseases (e.g., diabetes, liver disease, kidney disease, heart disease, respiratory disease, endocrine disease and/or metabolic disease).
6)have a history and/or a surgical history of digestive disease affecting digestion and absorption.
7)are judged unsuitable for the current study by the screening tests.
8)are diagnosed as anemic by the screening tests and unsuitable for frequent blood sampling.
9)have had diarrhea within the last one week prior to the screening tests.
10)have donated over 200 mL of blood and/or blood components within the last one month or over 400 mL of blood and/or blood components within the last three months prior to the current study.
11)are under treatment for or have a history of drug addiction and/or alcoholism.
12)are shift worker and/or midnight-shift worker.
13)are planning to participate in other clinical studies during test periods and/or had participated in other clinical studies within the last one month prior to the current study.
14)are planning to become pregnant after informed consent, pregnant or lactating.
15)take protein drink(or similar high-protein foods).
16)are planning to increase the amount of exercise during test periods.
17)are judged unsuitable for the current study by the investigator for other reasons.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Masahiko
Middle name
Last name Tokushima

Organization

Maebashi North Hospital

Division name

Director

Zip code

371-0054

Address

692 Shimohosoi-machi,Maebashi-shi,Gunma

TEL

027-235-3333

Email

sagawa@mc-connect.co.jp


Public contact

Name of contact person

1st name Yoshika
Middle name
Last name Komori

Organization

KSO Corporation

Division name

Sales department

Zip code

105-0023

Address

1-9-7 Shibaura, Minato-ku, Tokyo

TEL

03-3452-7733

Homepage URL


Email

eigyou27@kso.co.jp


Sponsor or person

Institute

KSO Corporation

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Kobuna Orthopedics Clinic

Address

5-656-17 Joto-machi, Maebashi-shi, Gunma

Tel

027-212-5608

Email

sagawa@mc-connect.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 04 Month 20 Day

Date of IRB


Anticipated trial start date

2021 Year 05 Month 10 Day

Last follow-up date

2021 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 05 Month 07 Day

Last modified on

2021 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050381


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name